Position in ANAB
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$24,637
+$17,546 QoQ
Shares Held
365
-13.9% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#176
of 211 holders
Holding Since
Sep 2020
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ANAB Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Pacer Advisors, Inc. holds $626,865,233 across 140 Biotechnology names. ANAB ranks #82 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
369,451 | $230,367,476 | |
| 2 | INCY |
Incyte Corp
|
1,431,426 | $162,266,451 | |
| 3 | EXEL |
Exelixis, Inc.
|
1,096,682 | $59,670,467 | |
| 4 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
72,465 | $35,995,539 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
146,264 | $35,245,236 | |
| 6 | BMRN |
Biomarin Pharmaceutical Inc
|
506,545 | $28,984,504 | |
| 7 | HALO |
Halozyme Therapeutics, Inc.
|
228,060 | $17,850,256 | |
| 8 | HRMY |
Harmony Biosciences Holdings, Inc.
|
348,239 | $12,679,381 |
All Filings in ANAB
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,637 | 365 | Shares | Sole | 2026-08-13 | |
| 2024-06-30 | $7,091 | 283 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $9,503 | 422 | Shares | Sole | 2024-05-10 | |
| 2021-03-31 | $45,729 | 2,122 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $34,657 | 1,612 | Shares | Sole | 2021-01-20 | |
| 2020-09-30 | $27,464 | 1,862 | Shares | Sole | 2020-10-19 | |
| No filing history on record for this holder in this stock. | ||||||